Granahan Investment Management - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$973,000
-38.4%
19,321
-26.8%
0.05%
-44.2%
Q2 2018$1,579,000
-52.1%
26,389
-63.3%
0.10%
-60.1%
Q1 2018$3,297,000
-43.5%
71,989
-50.8%
0.24%
-48.1%
Q4 2017$5,834,000
+22.8%
146,396
+23.2%
0.46%
+15.9%
Q3 2017$4,751,000
-7.3%
118,782
-0.1%
0.40%
-16.1%
Q2 2017$5,125,000
-14.2%
118,907
-37.7%
0.47%
-21.3%
Q1 2017$5,976,000
-66.7%
190,938
-73.2%
0.60%
-2.8%
Q4 2016$17,968,000
-10.0%
711,599
-11.8%
0.62%
-5.7%
Q3 2016$19,958,000
+13.8%
807,049
-6.3%
0.65%
+2.3%
Q2 2016$17,538,000
+195.0%
860,969
+120.9%
0.64%
+195.8%
Q1 2016$5,945,000389,8400.22%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders